Final version of the framework of key principles and criteria for guiding the design, conduct and analysis of preclinical efficacy and safety research

The framework will be reevaluated and refined with the conclusions of the prospective crosssite validation studies performed by WP23 at a second consensus meeting A final guidance will be agreed and then published A process for continuous improvement of the guidance will be agreed